The 4th Annual MarketsandMarkets Orphan Drugs and Rare Diseases Conference, scheduled for October 9–10 in London, United Kingdom ,aims to provide a valuable and broad platform to discuss recent advances in the development of life-saving therapies, critical issues, and strategies to enhance orphan drug development in near future. The conference will bring together scientists, researchers, entrepreneurs, academicians, medical officials, and technologists across the globe to discuss the newest findings in the areas of rare diseases and orphan drugs, helping to shape present and upcoming challenges in drug analysis. It gives participants the chance to interact with industry peers and participate in this scientific conference while staying informed about the most recent developments in the study of rare diseases.

Highlights

• Current landscape of Orphan Drugs across the globe.
• Latest Developments in Orphan drug regulations in Europe.
• Next Generation therapies treating uncommon/rare infections.
• Practices to enhance access to patient data.
• Clinical development & regulatory.
• Digital health and Artificial intelligence.
• Existing roadblocks in orphan drug development.
• Patient Advocacy groups and their role in market access
• Pricing and marketing plans for orphan medications.
• Revolutionary changes approaching rare diseases.
• Rare Genetic disorders: Novel Treatment Strategies.
• Rare Neurological and oncological disorders.
• Development of multi-omics methods for RD diagnosis.
• Role of Personalized Treatment in rare diseases.
• Regenerative Medicine Approaches to fight Complex RDs.

Read on sciencedz.net

Join us at the 2nd International Conference on Hemophilia and Rare Bleeding Disorder, in partnership with the World Federation of Hemophilia, taking place on October 7-8, 2023, at the prestigious Grand Hyatt Hotel in Abu Dhabi, UAE.

This exceptional conference, organized by the scientific and organizing committees, aims to showcase the latest advancements, exchange cutting-edge scientific research, and discuss the newest clinical applications in the field of Hemophilia and rare bleeding disorders. Focusing on improving care and treatment for patients in the UAE and the surrounding region, the comprehensive two-day program has been carefully curated by the scientific committee to address the current challenges and developments in this area.

Read on go.evvnt.com

Join us in 2023 for awesome CME, exercise, meet new colleagues, make friends, explore the island and of course the two Ironman Word Championships. A totally unique CME Experience. 

Read on ironmansportsmedicine.com

The course will take place in Jerusalem, at the historic Mishkenot Sha'ananim complex in the picturesque Yemin Moshe neighborhood of Jerusalem, which is the ideal venue for this interactive postgraduate teaching program.

Jerusalem is an exceptional location for the course. Sacred to the three major Monotheistic faiths, and with a history going back 5000 years, Jerusalem has something to offer everyone, from the colorful narrow alleyways of the bazaars of the old city, to the youthful and vibrant road side cafes and restaurants of modern Jerusalem.  The diversity of this beautiful city adds to the unique experience for all participants of this course.

We look forward to welcoming you to Jerusalem in October 2023.

Read on go.evvnt.com

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options, Current and evolving paradigms in precision oncology approach for management of common malignancies and Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.

Read on: education.binayfoundation.org

International Conference on Healthcare Information Technology and Healthcare Accuracy aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results on all aspects of Healthcare Information Technology and Healthcare Accuracy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Healthcare Information Technology and Healthcare Accuracy.

Read on waset.org

The Clinical Pathways Congress + Cancer Care Business Exchange is uniting clinical providers and business leaders to ensure cancer care solutions are delivered in a timely, effective, and cost-efficient manner. Gathering 400+ cancer care professionals in Boston, the Congress provides a unique opportunity to transform how the industry delivers and pays for cancer care. If you are involved in any stage of the pathways process or any aspect of cancer care, register today to gain insight, ask questions, measure outcomes, and explore ways to partner and expand pathway programs. Connect with colleagues and peers to gain valuable insights during 3-days of accredited educational sessions and networking events.

Read on go.evvnt.com

Immunotherapy is a rapidly evolving and growing field that has broad reaching impacts on the practice of medicine. This course is designed to teach participants about a wide range of immunotherapies for cancer treatment, future directions in immunotherapies, and practical management of patients receiving immunotherapies. Immunotherapies that will be discussed include adoptive cellular therapies, checkpoint-inhibitors, small molecules immune modulators, bi-specifics, and CAR-T therapy.

Read on ce.mayo.edu

During this 3 day CME course, experts in the field of genetic cardiology and cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of monogenetic, oligogenetic, and polygenic diseases affecting the heart and the blood vessels.

Topics covered will include genetics and genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies.

Read on go.evvnt.com

In its sixth year, The Constellation Forum is the premier event for Fortune 500 Executives, Healthcare Luminaries, Investors, Philanthropists, and Entrepreneurs. It aims to foster strategic partnerships, drive scientific advancements, and revolutionize health innovation. The 2023 program delves into healthcare's transition to AI and supercomputing, exploring the convergence of science, technology, culture, and society in healthcare innovation.

Read on constellationforum.com